Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
OPERATING ACTIVITIES:
Net income (loss)	$ (170,524)	$ 24,055
Adjustment to reconcile net income (loss) to net cash provided (used) by operating activities:
Gain on derivative liability	(282,000)
Depreciation		14,262
Changes in operating assets and liabilities:
Security deposit	(4,221)
Accounts receivable		(266,046)
Accounts payable / accrued expenses	101,645	325,841
Accrued interest	22,520	24,727
Accrued compensation	72,750	(58,333)
Net cash (used in) provided by operating activities	(259,830)	64,506
INVESTING ACTIVITIES:
Net cash provided (used) by investing activities
FINANCING ACTIVITIES:
Issuance Series P Preferred stock for cash	230,000
Repayment loan payable – related party	(100)	(35,340)
Payments on notes payable	0	(115,000)
Net cash provided (used) by financing activities	229,900	(150,340)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS	(29,930)	(85,834)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	68,108	115,747
CASH AND CASH EQUIVALENTS, END OF PERIOD	38,178	29,913
Supplemental Disclosures of Cash Flow Information:
Taxes paid	0
Interest paid	$ 0